In This Article:
The UK stock market has recently faced challenges, with the FTSE 100 index experiencing declines due to weak trade data from China, impacting companies closely tied to its economic performance. Amid these conditions, identifying stocks that may be undervalued becomes crucial as investors seek opportunities that could offer potential value despite broader market pressures.
Top 10 Undervalued Stocks Based On Cash Flows In The United Kingdom
Name | Current Price | Fair Value (Est) | Discount (Est) |
Hercules Site Services (AIM:HERC) | £0.495 | £0.93 | 46.5% |
Gaming Realms (AIM:GMR) | £0.367 | £0.71 | 48.7% |
GlobalData (AIM:DATA) | £1.785 | £3.57 | 49.9% |
On the Beach Group (LSE:OTB) | £2.565 | £5.03 | 49% |
ConvaTec Group (LSE:CTEC) | £2.502 | £4.92 | 49.1% |
Victrex (LSE:VCT) | £9.89 | £19.52 | 49.3% |
Informa (LSE:INF) | £8.38 | £16.32 | 48.7% |
Deliveroo (LSE:ROO) | £1.328 | £2.64 | 49.7% |
BATM Advanced Communications (LSE:BVC) | £0.192 | £0.38 | 49.4% |
St. James's Place (LSE:STJ) | £9.47 | £18.68 | 49.3% |
Let's explore several standout options from the results in the screener.
Restore
Overview: Restore plc, with a market cap of £295.76 million, offers services to offices and workplaces in both the public and private sectors primarily in the United Kingdom.
Operations: The company's revenue is derived from Secure Lifecycle Services, contributing £104.40 million, and Digital & Information Management, generating £172.50 million.
Estimated Discount To Fair Value: 29.4%
Restore is trading at £2.24, significantly below its estimated fair value of £3.17, indicating potential undervaluation based on discounted cash flows. Despite slower revenue growth forecasts of 3.6% annually and flat FY24 revenue due to market uncertainty, earnings are expected to grow significantly at 48.22% per year, outpacing the UK market average. However, interest payments are not well covered by earnings and the dividend yield of 2.39% lacks coverage by current profits.
-
According our earnings growth report, there's an indication that Restore might be ready to expand.
-
Dive into the specifics of Restore here with our thorough financial health report.
ConvaTec Group
Overview: ConvaTec Group PLC develops, manufactures, and sells medical products, services, and technologies across Europe, North America, and internationally with a market cap of £5.08 billion.
Operations: The company's revenue primarily comes from the development, manufacture, and sale of medical products and technologies, totaling $2.20 billion.
Estimated Discount To Fair Value: 49.1%
ConvaTec Group is trading at £2.50, well below its estimated fair value of £4.92, highlighting potential undervaluation based on discounted cash flows. Earnings have grown significantly by 117.9% in the past year and are forecast to grow 20.35% annually, surpassing UK market averages. However, despite robust profit growth projections and revenue growth forecasts exceeding the UK market rate of 3.6%, ConvaTec carries a high level of debt that may impact financial flexibility.